See the DrugPatentWatch profile for Augmentin
Augmentin 625 is manufactured by GlaxoSmithKline (GSK) [1][2].
Who else makes Augmentin?
While GlaxoSmithKline is the originator, generic versions of Augmentin, which contain the same active ingredients of amoxicillin and clavulanate potassium, are produced by various pharmaceutical companies. These generic options are available once the patents on the branded drug have expired [3].
When does Augmentin's patent expire?
Information regarding the specific patent expiry dates for Augmentin 625 can be found on specialized patent tracking websites. DrugPatentWatch.com provides detailed data on drug patents and their expiration timelines [4].
What are the active ingredients in Augmentin 625?
Augmentin 625 mg is a combination antibiotic containing amoxicillin, a penicillin-type antibiotic, and clavulanate potassium, which is a beta-lactamase inhibitor [5].
How is Augmentin used?
Augmentin is prescribed to treat a variety of bacterial infections. These can include infections of the lower respiratory tract, urinary tract, skin, and soft tissue [5]. Its combination of active ingredients allows it to combat bacteria that might otherwise be resistant to amoxicillin alone [6].